Guantánamo 9/11 Milestone Tracker United States v. KSM et al.

Procedural Critical-Path & June 2028 Trial Readiness Model

Pre-Trial Duration
5,214
Since 2012 Re-Arraignment
Current Trial Target
June 2028
Set by Col. Matthew McCall
Simulated Slippage
+0 Mo
On Schedule (Jun 2028)
Evidentiary Obstacle Index
78/100
High Interlocutory Exposure

Critical Path Procedural Dependencies

Target Readiness: 92%
Phase / Motion Track
2024
2024 H2
2025
2025 H2
2026
2026 H2
2027
2027 H2
2028
2028 H2

Master Pre-Trial Docket & Motion Log

Showing 7 Key Filings
Docket No. Motion Description Track / Rule Status Impact

Active Co-Defendants

Khalid Sheikh Mohammed (KSM) Lead Defendant
Walid bin Attash Pre-Trial Agreement Lit.
Mustafa al-Hawsawi Pre-Trial Agreement Lit.
Ali Abdul Aziz Ali (Ammar al-Baluchi) Torture Suppression Lead

Top 5 Postponement Risk Factors

1. SecDef Plea Nullification Litigation Critical Risk

Secretary Lloyd Austin's revocation of the Convening Authority's pre-trial agreements (removing the death penalty) creates historic separation-of-powers appeals before USCMCR and D.C. Circuit.

2. 'Clean Team' Statement Suppression Critical Risk

Defense challenges under M.C.R.E. 304 argue 2007 FBI confessions remain tainted by prior CIA Enhanced Interrogation Techniques (EITs) at overseas black sites.

3. M.C.R.E. 505 Classified Summaries High Risk

Review of hundreds of thousands of top-secret cables, operational cables, and covert witness substitution approvals requires protracted in-camera hearings.

4. Defense Counsel Resource Turnover Moderate Risk

Statutory requirement for 'learned counsel' in capital cases; departures or security clearance delays trigger months of onboarding continuances.

5. Capital Voir Dire & Isolation Logistics Moderate Risk

Guantánamo Camp Justice courtroom footprint requires sequestering high-ranking military officer panel members for an estimated 12-18 month evidentiary trial.

Legal Framework (MCA 2009)

M.C.R.E. 304: Prohibits admission of statements obtained by torture or cruel, inhuman, or degrading treatment.

M.C.R.E. 505: Military Commission counterpart to CIPA, governing handling and substitution of classified evidence.

10 U.S.C. § 950g: Governs interlocutory appeals to the U.S. Court of Military Commission Review (USCMCR) and D.C. Circuit.